The influence of moderate and chronic exercise training on the pharmacokinetics of procainamide and N-acetylprocainamide

Biopharmaceutics and Drug Disposition

Volumn 19, Issue 5, 1998, Pages 291-296

  Eddington, Natalie D ^a   Adekoya, Frank ^a   Kharidia, Jahnavi ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Exercise; N acetylprocainamide; Pharmacokinetics; Procainamide

Indexed keywords

ACECAINIDE; KETAMINE; PROCAINAMIDE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; SITTING; TREADMILL EXERCISE;

ACECAINIDE; ANIMALS; MALE; PHYSICAL CONDITIONING, ANIMAL; PROCAINAMIDE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031838384     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199807)19:5<291::AID-BDD106>3.0.CO;2-X     Document Type: Article

References (24)

1. S.N. Blair, H.W. Kohl, R.S. Paffenbarger, D.G. Clark, K.H. Cooper and L.W. Gibbons, Physical fitness and all-cause mortality. A prospective study of healthy men and women. J. Am. Med. Assoc., 262, 2395-2400 (1989).
2. R.S. Paffenbarger, R.T. Hyde, A.L. Wing and C.H. Steinmetz, A natural history of athleticism and cardiovascular health. J. Am. Med. Assoc., 252, 491-500 (1984).
3. Y. Chandrasheckhar and I.S. Anand, Exercise as a coronary protective factor. Am. Heart J., 122, 1723-1739 (1991).
4. J.M. Hagberg, Physiological adaptation to prolonged high intensity exercise training in patients with coronary artery disease. Med. Sci. Sports Exercise, 23, 661-667 (1991).
5. G.F. Fletcher, S.N. Blair, J. Blementhal, C. Caspersen, B. Chaitman, S. Epstein, H. Falls, E.S.S. Froelicher, V.F. Froelicher and I.L. Pina, Benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation, 86, 340-344 (1992).
6. S.M. Somani, S.K. Gupta, S. Frank and C.N. Corder, Effect of exercise on disposition and pharmacokinetics of drugs. Drug Dev. Res., 20, 251-275 (1990).
7. S. Horvarth, Review of energetics and blood flow in exercise. Diabetes, 28 (Supp 1), 33-38 (1979).
8. J.P. Knochel, L.N. Dotin and R.J. Hamburger, Heat stress, exercise and muscle injury: effects on urate metabolism, and renal function. Ann. Intern. Med., 81, 32-332 (1974).
9. L.B. Rowell, Human cardiovascular adjustment to exercise and thermal stress. Physiol. Rev., 54, 75-159 (1974).
10. M.A. Van Baak, Influence of exercise on the pharmacokinetics of drugs. Clin. Pharmacokinet., 19, 32-43 (1990).
11. G.H. Kamimori, S.M. Somani, R.G. Knowlton and R.M. Perkins, The effect of obesity and exercise on the pharmacokinetics of caffeine in lean and obese volunteers. Eur. J. Clin. Pharmacol., 31, 595-600 (1986).
12. R.D. Swartz, F.R. Sidell and S.A. Cucinell, Effects of physical stress on the disposition of drugs eliminated by the liver in man. J. Pharmacol. Exper. Ther., 14, 83-89 (1973).
13. J.J. Ducry, H. Howard, T. Zysset and J. Bicher, Liver function in physically trained subjects; Galactose elimination capacity, plasma disappearance of indocyanine green and aminopyrene metabolism in long distance runners. Dig, Dis. Sci., 24, 192-196 (1979).
14. J. Boel, L.B. Anderson, B. Rasmussen, S.H. Hansen and M. Dossing, Hepatic drug metabolism and physical fitness. Clin. Pharmacol. Ther. 36, 121-126 (1984).
15. R. Frenkl, A. Gyore, J. Meszaros and S. Szeberenyi, A study of the enzyme inducing effect of physical exercise in man. The 'trained liver'. J. Sports Med., 20, 371-376 (1980).
16. R. Frenkl, J. Meszaros and S. Szeberenyi, The effect of muscular exercise on the microsomal enzyme of the rat liver. Eur. J. Appl. Physiol., 44, 135-140 (1980).
17. W.W. Day and M. Weiner, Inhibition of hepatic drug metabolism and carbon tetrachloride toxicity in Fisher-344 rats by exercise. Biochem. Pharmacol., 42, 181-184 (1991).
18. A. Saborido, F. Molano and A. Megias, Effect of training and anabolic androgenic steroids on drug metabolism in rat liver. Med. Sci. Sports Exercise, 25, 815, 822 (1993).
19. T.J. Michaud, K.A. Bachmann, F.F. Andress, M.G. Flynn, G.P. Sherman and J. Rodriguez-zayas, Exercise training does not alter cytochrome P450 content and microsomal metabolism. Med. Sci. Sports Exercise, 26, 978-982 (1994).
20. W.W. Day, J.A. Cheskey and M. Weiner, Differential effects of swimming and running on microsomal metabolism in middle-aged and aged Fisher-344 rats. Mech. Ageing Dev., 63, 275-286 (1993).
21. C.A. Yiamouyiannis, R.A. Sanders, J.B. Watching and B.J. Martin, Chronic physical activity: hepatic hypertrophy and increased total biotransformarion enzyme activity. Biochem. Pharmacol., 44, 121-127 (1992).
22. J. Kharidia and N.D. Eddington, Application of computer-assisted radiotelemetry in the pharmacokinetic and pharmacoydynamic modeling procainamide and N-acetylprocainamide. J. Pharm. Sci., 85, 595-599 (1996).
23. M.L. Rocci and W.J. Jusko, Lagran program for area and moments in pharmacokinetic analysis. Comput. Prog. Biomed., 16, 203-216 (1983).
24. A. Saborido, F. Molano and A. Megias, Effect of training and anabolic androgenic steroids on drug metabolism in rat liver. Med. Sci. Sports Exercise, 25, 815-822 (1993).